Skip to main content
. 2021 Jun;24(6):815–825. doi: 10.22038/ijbms.2021.54554.12265

Table 1.

The in vitro antiproliferative activities of quinolines, ketoprofen and cisplatin against A2780 (drug-sensitive ovarian carcinoma cells) and A2780/RCIS (multidrug resistant ovarian carcinoma cells)

graphic file with name IJBMS-24-815-g004.jpg

a Compound concentration required to inhibit tumor cell proliferation by 50%. Data are presented as the mean ± SD from the dose−response curves of three independent experiments